↓ Skip to main content

Advances and Challenges of Liposome Assisted Drug Delivery

Overview of attention for article published in Frontiers in Pharmacology, December 2015
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (96th percentile)
  • High Attention Score compared to outputs of the same age and source (97th percentile)

Mentioned by

news
8 news outlets
blogs
1 blog
twitter
4 X users
patent
1 patent
wikipedia
2 Wikipedia pages

Readers on

mendeley
2893 Mendeley
citeulike
1 CiteULike
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Advances and Challenges of Liposome Assisted Drug Delivery
Published in
Frontiers in Pharmacology, December 2015
DOI 10.3389/fphar.2015.00286
Pubmed ID
Authors

Lisa Sercombe, Tejaswi Veerati, Fatemeh Moheimani, Sherry Y. Wu, Anil K. Sood, Susan Hua

Abstract

The application of liposomes to assist drug delivery has already had a major impact on many biomedical areas. They have been shown to be beneficial for stabilizing therapeutic compounds, overcoming obstacles to cellular and tissue uptake, and improving biodistribution of compounds to target sites in vivo. This enables effective delivery of encapsulated compounds to target sites while minimizing systemic toxicity. Liposomes present as an attractive delivery system due to their flexible physicochemical and biophysical properties, which allow easy manipulation to address different delivery considerations. Despite considerable research in the last 50 years and the plethora of positive results in preclinical studies, the clinical translation of liposome assisted drug delivery platforms has progressed incrementally. In this review, we will discuss the advances in liposome assisted drug delivery, biological challenges that still remain, and current clinical and experimental use of liposomes for biomedical applications. The translational obstacles of liposomal technology will also be presented.

X Demographics

X Demographics

The data shown below were collected from the profiles of 4 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 2,893 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Brazil 2 <1%
Indonesia 1 <1%
Norway 1 <1%
France 1 <1%
Taiwan 1 <1%
United States 1 <1%
Unknown 2886 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 489 17%
Student > Bachelor 436 15%
Student > Master 394 14%
Researcher 240 8%
Student > Doctoral Student 109 4%
Other 265 9%
Unknown 960 33%
Readers by discipline Count As %
Pharmacology, Toxicology and Pharmaceutical Science 392 14%
Biochemistry, Genetics and Molecular Biology 379 13%
Chemistry 293 10%
Engineering 160 6%
Agricultural and Biological Sciences 152 5%
Other 434 15%
Unknown 1083 37%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 67. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 17 October 2023.
All research outputs
#650,795
of 26,017,215 outputs
Outputs from Frontiers in Pharmacology
#238
of 20,002 outputs
Outputs of similar age
#10,624
of 401,213 outputs
Outputs of similar age from Frontiers in Pharmacology
#2
of 88 outputs
Altmetric has tracked 26,017,215 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 96th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 20,002 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.4. This one has done particularly well, scoring higher than 98% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 401,213 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 96% of its contemporaries.
We're also able to compare this research output to 88 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 97% of its contemporaries.